January 22, 2018 / 8:18 AM / 6 months ago

BRIEF-Shenzhen Neptunus Bioengineering unit passes FDA approval for new drug clinical trial

Jan 22(Reuters) - Shenzhen Neptunus Bioengineering Co Ltd :

* Says its wholly owned pharma tech unit received FDA approval for anti-tumor new drug clinical trail from U.S Food and Drug Administration

* The unit will be able to conduct clinical trial of anti-tumor new drug in the United States after receiving the FDA approval

Source text in Chinese: goo.gl/Ucdtfz

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below